



























lasting  hearing  loss  and  tinnitus  are  problematic  conse- 
quences in many cases [2]. Notwithstanding, the pathoge-
nesis is still largely unknown even today and is subject to 








ver,  a  monocausal  occurrence  is  rather  unlikely,  so  that 
numerous other causalities such as viral infections, immune 













































































For  this  purpose,  the  patients  were  treated  within  the 
Medical  Care  Unit,  Kempten-Allgäu  and  the  University 

















triglycerides  and  lipoprotein(a),  sodium,  potassium,  cal-
cium,  urea,  glucose,  creatinine,  total  protein,  bilirubin,   



















































































































































































































































































methods  [15,  16].  Furthermore,  the  reduction  of  serum 
cholesterol increases the release of nitric oxide and could 
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